Panacea Life Sciences Holdings, Inc. (PLSH)
OTCMKTS · Delayed Price · Currency is USD
0.0450
+0.0050 (12.38%)
Feb 10, 2026, 10:19 AM EST
Panacea Life Sciences Holdings Employees
Panacea Life Sciences Holdings had 40 employees as of December 31, 2023. The number of employees increased by 21 or 110.53% compared to the previous year.
Employees
40
Change (1Y)
21
Growth (1Y)
110.53%
Revenue / Employee
$69,098
Profits / Employee
-$191,752
Market Cap
2.67M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2023 | 40 | 21 | 110.53% | 40 | 0 |
| Dec 31, 2022 | 19 | -16 | -45.71% | 19 | 0 |
| Dec 31, 2021 | 35 | - | - | 29 | 6 |
Panacea Life Sciences Holdings News
- 3 months ago - Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. Launch Benivita PLSH -- a New Era in Direct-to-Consumer Virtual Benefits - PRNewsWire
- 1 year ago - Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products - GlobeNewsWire
- 2 years ago - Panacea Life Sciences Holdings, Inc. Completes Acquisition of N7 Enterprises With Eight Natural Health and Wellness Retail and One Distribution Center Locations in the Tampa, Florida area - GlobeNewsWire
- 2 years ago - Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise - GlobeNewsWire
- 2 years ago - Panacea Life Sciences Holdings, Inc. Celebrates National CBD Day (August 8th) By Shifting To An “Everyday Low Pricing Model” To Meet Customer Needs - GlobeNewsWire
- 2 years ago - Panacea Life Sciences Holdings, Inc. Continues Pursuit of High Growth Health and Wellness Products with Acquisition of Sierra Sage, LLC and Halucenex from Melodial Global Health (formerly Creso Pharma Limited) - GlobeNewsWire
- 2 years ago - Panacea Life Sciences Holdings, Inc. Announces CBD/CBG Clinical Trial Findings for the Management of Irritable Bowel Symptoms - GlobeNewsWire
- 2 years ago - Panacea Life Sciences Holdings, Inc. Chief Scientific Officer, Dr. James Baumgartner, is Featured on The Stock Day Podcast - Accesswire